Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.82366 | 35 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.76727 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.77135 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.75583 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.76126 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.86749 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.91544 | 37 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.73644 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.08621 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74782 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.7657 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.72148 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.77408 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.76017 | 34 |